One of the characteristic features of prostate carcinoma is its marked variation in biologic behavior. DNA quantitation has been studied in prostate carcinoma using a variety of techniques. Evaluation of tumor ploidy suggests that this may be the best predictor of the biologic behavior of prostate cancer in individual patients. This comprehensive review addresses the current studies, stage by stage, to clarify the clinical significance of these findings.
Peters-Gee, Jill M.
"An Update on the Role of Ploidy in Prostate Carcinoma,"
Henry Ford Hospital Medical Journal
: Vol. 40
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol40/iss1/23